×
-0.00261780104712048 -0.0091623036649215 -0.00392670157068066 0.0104712041884817 0.0104712041884817 0.0078534031413612 0.00523560209424084 0.0235602094240837
Stockreport

NewLink shares fall on late-stage trial changes [MarketWatch]

NEWLINK GENETICS (NLNK)  More Company Research Source: MarketWatch
Last newlink genetics earnings: 3/1 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.linkp.com/investor-relations
PDF NewLink shares fall on late-stage trial changes NewLink Genetics Corp. NLNK, -13.87% shares fell as much as 15% in premarket trade Monday after the company said it won't proceed as planned with a late-stage trial of its indoximod for advanced melanoma. The company will instead look at the possibility of another randomized evaluation of the drug for melanoma, a decision made after "the failure of a competitor's trial... in a similar clinical setting," NewLink said, referring to the failure of a similar drug in a Merck MRK, +3.30% and Incyte INCY, -1.25% trial earlier this month . The phase 3 trial, called Indigo301, aimed to test indoximod in combination with Merck's cancer drug Keytruda or Bristol-Myers Squibb's cancer drug Opdivo BMY, -5.85% Sunday's NewLink announcement wasn't unexpected, as the company previously said it planned to review its clinical programs after the Merck/Incyte trial results. More unexpected, however, was the decision to stick its news at the end o [Read more]

IMPACT SNAPSHOT EVENT TIME: NLNK
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS